Since alterations in the TOM complex (made up of TOMM22, TOMM40, TOMM40L and TOMM70) have been linked with AD and PD pathogenesis, TMV has great potential as a therapeutic tool for those NDDs [160,161]. The gene discussed is TOMM22; the disease is Parkinson disease.